Clinical Trials · NCT00913055
Open Label Study of Octreotide Implant in Patients With Acromegaly
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Enrollment
- 34
- Start date
- Feb 2007
- Locations
- See registry
- Primary endpoint
- Study in Acromegaly